@WHO: WHO’s emergency use listing procedure assesses the quality, safety and efficacy of #COVID19 vaccines as a prerequisite for COVAX vaccine supply. It also allows countries to expedite their own regulatory approval to import & administer COVID-19 vaccines. https://t.co/jJyS1hiz44

http://twitter.com/WHO
via IFTTT